Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(14 sites)
Belgium
Cliniques Universitaires Saint-Luc, Brussels France
Centre Antoine Lacassagne, Nice Institut Curie - Hôpital de Paris, Paris Germany
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin Universitaets Krankenhaus Eppendorf - Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center, Hamburg Universitaetsklinikum Heidelberg - Frauenklinik / Hautklinik, Heidelberg Netherlands
Leiden University Medical Centre, Leiden Poland
Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw Spain
Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia), L'Hospitalet de Llobregat Hospital Clinico Universitario De Valladolid, Valladolid Sweden
Sahlgrenska Universitetssjukhuset, Gothenburg United Kingdom
The Clatterbridge cancer Center NHS foundation Trust - Clatterbridge Cancer Center - Liverpool, Liverpool East and North Hertfordshire NHS Trust - Mount Vernon Hospital, Northwood